Literature DB >> 27305861

Topically applied fatty acids are elongated before incorporation in the stratum corneum lipid matrix in compromised skin.

Tineke Berkers1, Lauri van Dijk1, Samira Absalah1, Jeroen van Smeden1, Joke A Bouwstra1.   

Abstract

In several skin diseases, both the lipid composition and organization in the stratum corneum (SC) are altered which contributes to the impaired skin barrier function in patients. One of the approaches for skin barrier repair is treatment with topical formulations to normalize SC lipid composition and organization. Vernix caseosa (VC), a white cheesy cream on the skin during gestational delivery, has shown to enhance skin barrier repair. In this study, we examined how a fatty acid (FA) containing formulation mimicking the lipid composition of VC interacts with the lipid matrix in the SC. The formulation was applied on ex vivo human skin after SC removal. Subsequently, the ex vivo human skin generated SC during culture. The effect of FA containing formulations on the lipid organization and composition in the regenerated SC was analysed by Fourier transform infrared (FTIR) spectroscopy and liquid chromatography mass spectroscopy (LC/MS), respectively. FTIR results demonstrate that the FAs are intercalated in the lipid matrix of the regenerated SC and partition in the same lattice with the endogenous SC lipids, thereby enhancing the fraction of lipids forming an orthorhombic (very dense) packing in the SC. LC/MS data show that the topically applied FAs are elongated before intercalation in the lipid matrix and are thus involved in the lipid biosynthesis in the skin.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  lipid organization; lipid synthesis; skin barrier repair; topical formulation

Mesh:

Substances:

Year:  2017        PMID: 27305861     DOI: 10.1111/exd.13116

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  7 in total

1.  An Overview on the Properties of Ximenia Oil Used as Cosmetic in Angola.

Authors:  Gabriel Satoto; Ana Sofia Fernandes; Nuno Saraiva; Fernando Santos; Nuno Neng; José Manuel Nogueira; Tânia Santos de Almeida; Maria Eduarda M Araújo
Journal:  Biomolecules       Date:  2019-12-20

2.  Contribution of Palmitic Acid to Epidermal Morphogenesis and Lipid Barrier Formation in Human Skin Equivalents.

Authors:  Arnout Mieremet; Richard Helder; Andreea Nadaban; Gert Gooris; Walter Boiten; Abdoelwaheb El Ghalbzouri; Joke A Bouwstra
Journal:  Int J Mol Sci       Date:  2019-12-02       Impact factor: 5.923

3.  A Novel Effect of Lipids Extracted from Vernix Caseosa on Regulation of Filaggrin Expression in Human Epidermal Keratinocytes.

Authors:  Wu Qiao; Tinghan Jia; Hongjian Gu; Ruihua Guo; Ken Kaku; Wenhui Wu
Journal:  Ann Dermatol       Date:  2019-10-31       Impact factor: 1.444

4.  Alteration of barrier properties, stratum corneum ceramides and microbiome composition in response to lotion application on cosmetic dry skin.

Authors:  Barry Murphy; Sally Grimshaw; Michael Hoptroff; Sarah Paterson; David Arnold; Andrew Cawley; Suzanne E Adams; Francesco Falciani; Tony Dadd; Richard Eccles; Alex Mitchell; William F Lathrop; Diana Marrero; Galina Yarova; Ana Villa; John S Bajor; Lin Feng; Dawn Mihalov; Andrew E Mayes
Journal:  Sci Rep       Date:  2022-03-26       Impact factor: 4.379

5.  Topical application of lipids to correct abnormalities in the epidermal lipid barrier.

Authors:  Alexandra C Kendall; Anna Nicolaou
Journal:  Br J Dermatol       Date:  2022-05       Impact factor: 11.113

6.  Multitargeted Approach for the Optimization of Morphogenesis and Barrier Formation in Human Skin Equivalents.

Authors:  Arnout Mieremet; Richard W J Helder; Andreea Nadaban; Walter A Boiten; Gert S Gooris; Abdoelwaheb El Ghalbzouri; Joke A Bouwstra
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

7.  Topically Applied Ceramides Interact with the Stratum Corneum Lipid Matrix in Compromised Ex Vivo Skin.

Authors:  Tineke Berkers; Dani Visscher; Gert S Gooris; Joke A Bouwstra
Journal:  Pharm Res       Date:  2018-02-06       Impact factor: 4.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.